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Abstract. Extracellular matrix (ECM) and growth fac- 
tors are potent regulators of cell phenotype. These bio- 
logical mediators of cellular responses are potentially 
interactive and as such could drive cells through pro- 
gressive phenotypes to create new tissue as in morpho- 
genesis and wound repair. In fact, ECM composition 
changes during tissue formation accompanied by alter- 
ations in cell growth and migration. How alterations in 
the ECM regulate cell activities is poorly defined. To 
address this question in wound repair, we cultured nor- 
mal human dermal skin fibroblasts in relaxed collagen 
gels, fibronectin-rich cultures or stressed fibrin gels, 
and stressed collagen gels to model normal dermis, 
early wound provisional matrix, and late granulation 
tissue, respectively. Integrin subunits, ~2, ~3, and ors, 
that define receptor specificity for collagen and provi- 
sional matrix, respectively, were measured at mRNA 
steady-state level before and after stimulation with 
platelet-derived growth factor-BB (PDGF-BB), a po- 
tent mitogen and chemoattractant for fibroblasts. Fi- 
bronectin-rich cultures and fibrin gels supported 
PDGF-BB induction of et  3 and et5 mRNA. In contrast, 
both stressed and relaxed collagen attenuated these re- 
sponses while promoting maximal a2 mRNA expres- 
sion. Posttranscriptional regulation was an important 
mechanism in this differential response. Together 
PDGF-BB and collagen gels promoted et2, but not et  3 
and et  5, mRNA stability. Conversely, when fibroblasts 
were in fibronectin-rich cultures, PDGF-BB promoted 
et  3 and o~5, but not a2, mRNA stability. We suggest that 
ECM alterations during wound healing or any new tis- 
sue formation cause cells to respond differently to re- 
peated growth factor stimuli. An ordered progression 
of cell phenotypes results, ultimately consummating tis- 
sue repair or morphogenesis. 
URING cutaneous wound repair, cells must attach to 
new matrix molecules and migrate (Welch et al., 
1990). Soon after wounding, a provisional matrix 
of fibronectin, fibrinogen, fibrin, and vitronectin forms in 
the wound area (Gailit and Clark, 1994a). In the fibrin net- 
work, platelets release growth factors such as PDGF that 
stimulate proliferation and chemoattraction of fibroblasts 
(Deuel et al., 1991). Activated fibroblasts must move from 
surrounding collagenous connective tissues into a fibrin/fi- 
bronectin-filled wound and subsequently synthesize new 
collagenous matrix. Clearly, fibroblast responses to these 
extracellular matrix (ECM) 1 molecules and growth factors 
are essential for the healing process to progress. 
To address the mechanisms by which ECM molecules 
regulate cell activities, three-dimensional ECM-based cul- 
ture systems are increasingly used. Since type I collagen is 
a ubiquitous component of dermal ECM much attention 
has been devoted to cells cultured in stressed and/or re- 
laxed collagen gels. The relaxed collagen gel is considered 
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a reconstituted dermal model whereas the stressed gel is 
similar to late granulation tissue (Grinnell, 1994).  Com- 
pared to fibroblast cultures on plastic, cells in a  relaxed 
collagen gel exhibit little proliferative response to PDGF 
(Lin  and  Grinnell,  1993)  and  little collagen production 
(Eckes  et  al.,  1993).  Nevertheless, cells  harvested from 
stressed collagen gels proliferate and synthesize collagen 
robustly. Collagen matrices can affect fibroblasts function 
by altering both gene expression and second messenger 
pathways. Fibroblasts in collagen gels that are stimulated 
with PDGF decrease Ctl(I  ) collagen gene expression (Ber- 
thod et al., 1994; Eckes et al., 1993), increase collagen re- 
ceptor gene expression (Klein et al.,  1991), and decrease 
autophosphorylation of PDGF receptors  (Lin and Grin- 
nell, 1993).  In contrast, fibroblasts in fibrin gels or in fi- 
bronectin-rich  tissue  culture  conditions,, proliferate  ro- 
bustly and produce exuberant ECM (Clark et al., 1995a; 
Clark,  R.  A.  F.,  G.  A.  McCoy, J.  M.  Folkvord, and J. 
McPherson, manuscript submitted for publication; Grin- 
nell et al., 1989; Nakagawa et al., 1989). 
The molecules primarily responsible for cell adherence 
to ECM are integrins, a family of cell surface receptors. In- 
tegrins are heterodimers composed of an o~ chain and a 13 
chain. 131 integrin can form a complex with at least ten dif- 
ferent et subunits, namely ctl-ot  9 and et  v (Hynes, 1992; Haas 
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ous collagen types and laminin, et313t binds to the arginine- 
glycine-aspartic acid (RGD) sequence in fibronectin and 
laminin. 0t3131 interaction with native collagen is controver- 
sial  and  at  best  a  weak  interaction  (Pfaff et  al.,  1993; 
Yamamoto and Yamamoto, 1994). et5131 is specific for the 
fibronectin RGD sequence. 
The expression of integrins is regulated by both growth 
factors  and  ECM  proteins.  For  example,  transforming 
growth factor-131 (TGF-131),  released from platelets after 
wounding, upregulates 131 and 133 integrin receptors (En- 
enstein et al.,  1992; Heino et al.,  1989;  Heino and Mas- 
sague, 1989). PDGF-BB, also released from platelets, stim- 
ulates  gene  expression of integrin  131  in  Swiss  3T3  cells 
(Bellas et al., 1991), et  5 and 133 in aortic smooth muscle cells 
(Janat et al.,  1992)  and ot  2 in human foreskin fibroblasts 
(Ahlen and Kristofer, 1994).  Type I collagen upregulates 
o[  2 integrin mRNA  level in  human  fibroblast and  mela- 
noma cell lines (Klein et al., 1991). Thus, the level of spe- 
cific integrins is probably controlled by interactive signals 
from both ECM molecules and growth factors in the peri- 
cellular environment. 
The global goal of our laboratory is to investigate how 
variations in ECM composition during wound healing cor- 
relates with changes in cell growth and migration. We hy- 
pothesized that the alteration in ECM during wound heal- 
ing differentially regulates cell response to cytokines such 
as  PDGF,  resulting in  a  progression of cell phenotypes 
necessary for the ordered healing of wounds. Specifically, 
we hypothesize that fibrin and collagen differentially regu- 
late integrin gene expression, which in turn affects how fi- 
broblasts  physically  and  biochemically  relate  to  ECM. 
Multiple cycles of these events would lead to a progression 
of cell-ECM interaction. 
To test our hypothesis, in vitro systems to model differ- 
ent stages of wound repair were established. Relaxed col- 
lagen gels, stressed fibrin gels or fibronectin-rich cultures, 
and stressed collagen gels were used to model normal der- 
mis, early wound provisional matrix, and late granulation 
tissue, respectively. Steady-state levels of specific integrin 
mRNAs, collagen integrin subunit, et  2, and provisional ma- 
trix integrin subunits, ot  3 and ets, were analyzed in these 
different  ECM  environments.  By  adding  PDGF-BB  to 
these  culture  systems, we  found that  fibrin gels  and fi- 
bronectin-rich cultures supported induction of provisional 
matrix receptor ~3 and tx5 mRNAs while collagen gels fa- 
cilitated induction of collagen receptor et  2 mRNAs and at- 
tenuated provisional matrix receptor responses. Thus fi- 
broblasts  surrounded  by  fibrin  respond  to  PDGF  by 
expressing  receptors  necessary  for  interaction  with  the 
wound provisional matrix.  In contrast fibroblasts in col- 
lagen increase their collagen receptors and fail to support 
PDGF-induction of provisional matrix receptors. Finally, 
PDGF-BB  was  able  to  prolong  half-lives  of ~x  3 and  ct  5 
mRNAs in stressed fibrin gel. Collagen gels failed to sup- 
port  this  response.  In  contrast,  ~x  2 mRNA  stability was 
greatly increased by PDGF-BB when the cells were cul- 
tured in collagen but not when cultured on plastic. These 
results suggest that coordinate signals from PDGF-BB and 
fibrin increase the epigenetic pressure in fibroblasts to ex- 
press provisional matrix receptors which may be one of 
the inductive processes of granulation tissue formation. In 
addition,  one  new  mechanism,  modulation  of  integrin 
mRNA  decay  rate,  is  found  to  greatly  alter  integrin 
mRNA steady state. 
Materials and Methods 
Cell Culture 
Human fibroblasts cultures were established by outgrowth from healthy 
human skin biopsies. The cells were maintained in DMEM (GIBCO BRL, 
Gaithersburg, MD), supplemented with 10%  FCS (Atlanta Biologicals, 
Norcross,  GA),  100  U/ml penicillin,  100  U/ml  streptomycin  (GIBCO 
BRL), and grown in a humidified atmosphere of 5% CO2 and 95% air at 
37°C. Cells between population doubling levels (PDL) 15 and 20 (the 6th 
and 10th passage) were used for the experiments. 
Preparation of Collagen and Fibrin Gels 
Collagen gels were prepared with pepsin-solubilized bovine dermal col- 
lagen dissolved in 0.012 M HCI (Vitrogen 100). The bovine skin collagen 
is 99.9% pure containing 95-98% type I collagen and type III as the re- 
mainder (Cetrix Laboratories, Palo Alto, CA). Collagen for cultures was 
prepared by mixing 2.0 mg/ml of type I collagen, 100 U/ml penicillin, 100 
U/ml streptomycin, and 10% FCS in DMEM at pH 7.0-7.4. Human der- 
mal fibroblasts from subconfluent cultures were mixed with 10 ml of col- 
lagen solution for a final concentration of 5  x  105 cells/ml. The collagen 
cell suspension (4 ml) was immediately placed onto 60-mm tissue culture 
dishes (Falcon, Becton Dickinson, Lincoln Park, NJ) and incubated for 
2 h at 37°C before the addition of 5 ml of 10% FCS/DMEM to each dish. 
Relaxed collagen gels were obtained by detaching the gels from the plate 
after  polymerization  and  they  were  allowed  to  float  in  the  medium. 
Stressed gels remained anchored to the culture dishes. 
Fibrin for cultures was prepared by mixing 3.0 mg/ml human plasma fi- 
brinogen (>98% clottable proteins and homogenous by SDS-PAGE, Cal- 
biotech, La Jolla, CA), 100 U/ml penicillin, 100 U/ml streptomycin, and 
10% FCS in DMEM. 0.1 N HC1 was added to adjust pH at 7.0-7.4. Human 
dermal fibroblasts from subconfluent cultures were mixed with the fibrin- 
ogen solution for a final concentration of 5  x  105 cells/ml. Immediately 
thereafter human thrombin (GIBCO BRL) was added at 0.2 U/ml. The fi- 
brin(ogen) cell suspensions (4 ml) were placed onto 60-mm petri dishes 
(Falcon). After gentle stirring, gels formed in less than 5 min. After 2 h of 
incubation at 37°C, 5 ml of 10% FCS/DMEM was added. 
After incubation at 37°C in 95% air, 5% CO2 and 100% humidity for 24 h, 
the cultures were carefully washed two times in DMEM, switched to 1.0% 
FCS/DMEM and remained in the same media for 4 d with medium change 
every 2 d. In experiments with PDGF-BB (ZymoGenetics, Seattle, WA), 
the growth factor was added on the fourth day of culturing. All subse- 
quent experiments were performed according to specific conditions. 
PDGF-BB and Platelet Releasate 
Sterile,  endotoxin-free, recombinant BB  isoform of PDGF  was kindly 
provided  by  Charles  Hart  (Zymogenetics, Seattle,  WA)  (Hart  et  al., 
1988). 
Platelets were isolated from pooled human blood according to previ- 
ously described methods (Knighton et al., 1986)  and kindly provided by 
Curative Technology Inc.  (East Setauket, NY). The platelet-containing 
pellet was resuspended in platelet buffer which contained 50 mM N-2- 
hydroxyethylpiperazine-N-2-ethanesulfonic  acid (Hepes), 100 mM NaC1, 6 
mM KCI and 3 mM glucose to a final platelet concentration of 5  x  109 
platelets/ml.  Bovine  thrombin  (Thrombinar,  Armour  Pharmaceutical, 
Kankakee, IL) was then added at a concentration of i  U/109 platelets and 
the thrombin platelet mixture incubated at room temperature for 10 min. 
After granule release, the aggregated platelets were resuspended by aspi- 
ration and centrifuged for 10 min at 2,000 g at room temperature. The su- 
pernatant containing the released platelet factors was retained and diluted 
1:10 in DMEM. PDGF concentrations in the platelet releasate were deter- 
mined using a  sandwich EIA with anti-PDGF from Collaborative  Re- 
search  Inc.  (Bedford,  MA)  which recognizes all  PDGF  isoforms, and 
PDGF-AB  (Boehringer Mannheim, Indianapolis, IN)  for  the standard 
curve. 
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Total RNA was isolated from monolayers and gel cultures using a modifi- 
cation  of guanidinium  thiocyanate method (Chromczynski and  Sacchi, 
1987). After stressed gel cultures were spun in a microcentrifuge at 14,000 g 
to remove H20, gel cultures of both types were dissolved in 4 M guanidin- 
ium isothiocyanate and repeatedly passed through a 20 1/2-gauge  needle. 
For Northern blot hybridization, 5-7.5 p,g of total RNA was treated with 
glyoxal/DMSO, separated by electrophoresis on a 1% agarose gel in 10 mM 
phosphate buffer, pH 7.0, and transferred to Hybond  + nylon membranes 
(Amersham, Arlington Heights, IL). Ethidium bromide (0.5  }xg/ml) was 
included in the gel to monitor equal loading by the quantity of 18S and 
28S  ribosomal RNA  present,  eDNA  probes were  labeled with  [a-32P] 
dCTP by the random primer procedure (Du Pont New England Nuclear, 
Boston, MA). Oligonucleotide probes were end-labeled with [~-32p]ATP 
(Du Pont NEN) and polynucleotide kinase (Boehringer Mannheim). The 
filters were hybridized to the labeled probes in QuickHyb solution (Strat- 
agene, La Jolla, CA) for 3 h  at 68°C and washed according to manufac- 
turer's protocol. After autoradiography (Kodak X-Omat AR) at -80°C for 
optimal exposure, signal intensity was determined by densitometry. Values 
shown are representative of at least two independent experiments. Human 
cDNAs were generous gifts from Dr. Yoshikazu Takada, Scripps Institute 
for ~2 (Takada and Hernler, 1989) and %  (Takada et al., 1991). a 5 cDNAs 
were purchased from GIBCO BRL. An oligonucleotide complementary 
to 28S ribosomal RNA was purchased from Clontech (Palo Alto, CA). 
Measurement of mRNA Stability 
The  procedure  was  a  modification of the method by  Penttinen et  al. 
(1988). After i  d in 10% FCS/DMEM, cells on plastic and in collagen gels 
were cultured in 1% FCS/DMEM for an additional 72 h. Unless otherwise 
specified, PDGF-BB was added at 30 ng/ml 15 min before the addition of 
60  IxM  5,6-dichloro-l-13-D-ribofuranosyl-benzimidazole  (DRB,  Sigma 
Chem. Co., St. Louis, MO), an inhibitor of transcription initiation (Zando- 
meni et al.,  1983). Total RNA isolation and Northern analysis were per- 
formed as described above. 
Porcine Cutaneous Wounds and 
Immunofluorescence Staining 
Full-thickness cutaneous wounds were made with an 8-mm punch on the 
backs  of White  Yorkskire  pigs  and  harvested  at  the  times  indicated 
(Welch et al., 1990). Specimens were bisected; one half was fixed in forma- 
lin and stained with Masson trichrome; the other half was frozen in liquid 
nitrogen for immunofluorescence studies. Frozen sections were prepared 
for immunofluorescence as previously described (Folkvord et al., 1989). 
The following antibodies were used to identify integrins of interest. The 
monoclonal antibodies against ct  2 and u 3 (Clones PIE6 and PIB5, respec- 
tively) were purchased from GIBCO BRL. A  rabbit polyclonal antibody 
against the carboxy-terminal sequence AQLKPPATSDA, from the cyto- 
plasmic tail of as, was the gift of John McDonald (Mayo Clinic). 
All antibodies were used at dilutions that gave maximal specific fluo- 
rescence and  minimal background fluorescence on frozen tissue speci- 
mens. Immunofluorescence controls included sections stained with an ir- 
relevant monoclonal antibody instead of the primary antibody, as well as 
sections in which either the primary and/or secondary antibody(ies) was 
omitted from the staining procedure. Bound antibody was detected by the 
avidin-biotin-complex (ABC) technique as previously described (Folkvord 
et al., 1989). Nonspecific staining was blocked by incubating the tissue sec- 
tions with 50 }xg/ml  horse IgG, 5% human serum and 200 }xg/ml Avidin D 
for 60 min. The slides were incubated with primary antibody solution in 
Figure 1.  Expression of integrin subunits in porcine dermis and wound fibroblasts. Normal porcine skin and wounds were stained with 
antibodies against c~  2, a3, and as, respectively. (A-C) et2; (D-F) et3; (G-D or5; (A, D, and G) normal pig dermis; (B, E, and/-/) granulation 
tissue in day 5 wounds; (C, F, and/)  granulation tissue in day 7 wounds. Bar, 10 p~m. 
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formation, we prepared tissue specimens from normal por- 
cine skin and 4, 5, and 7 d porcine granulation tissue (GT). 
Previous  investigations  have  showed  that  4-  and  5-d 
wounds mainly have a network of fibrin or fibronectin, re- 
spectively, whereas 7-d wounds have  a  substantial orga- 
nized collagen fiber network (Welch et al., 1990; Clark et 
al., 1995a). Furthermore, PDGF is abundantly present in 
wounds during these early time periods but not in normal 
dermis (Ansel et al., 1993). Fig. 1 shows that ~2 expression 
was greatest in collagen-rich day 7 wounds (panel C) com- 
pared to either normal dermis (panel A) or fibronectin- 
rich day 5 wounds (panel B), while %  and ~5 expression 
Figure 2.  Time course of PDGF-BB effects  on integfin mRNA 
levels in fibroblasts cultured on plastic. Fibroblasts were cultured 
1 d  in 10%  FCS/DMEM followed by 3 d in 1% FCS/DMEM. 
Such cultures were then stimulated by 30 ng/ml PDGF-BB and 
incubated for the time indicated. Total RNA was probed with hu- 
man integrin cDNAs, or2, or3, and as, respectively.  Equal loading 
was  monitored by UV light examination of ethidium bromide 
stained gel and confirmed by hybridization of the same blot with 
32p-labeled probe for 28S ribosomal RNA. 
PBS containing 0.02% sodium azide and 0.1% BSA (Miles, Kankakee, 
IL) overnight  at 4°C,  washed three times, and incubated  with 2.5 o.g/ml  bi- 
otinylated secondary antibody (Vector Laboratories, Burlingame, CA) 
followed by 15 ~g/ml  streptavidin-FITC  (Vector Laboratories) for 30 min 
at room temperature. 
Vectashield mounting medium (Vector Laboratories) was used to re- 
tard quenching. Slides were photographed on 35-mm Tmax 400 film 
(Eastman Kodak, Rochester, NY) using  a Nikon Microphot FXA epifluo- 
rescence microscope equipped with a halogen light source, a 470--490-nm 
excitation filter and a 515-nm  barrier filter for fluorescein  emission.  The 
filters selected excluded cross excitation resulting in pure yellow/green 
fluorescein  and red rhodamine  fluorescence. 
Results 
Progressive Expression of a2, ~3, and a5 Integrin 
Subunit during Wound Healing Process 
To  understand the  relation between integrin expression 
Figure 3.  Dose  dependence  of  PDGF-BB  effects  on  integrin 
mRNA levels in fibroblasts cultured on plastic. Fibroblasts were 
cultured 1 d in 10% FCS/DMEM followed by 3 d in 1%  FCS/ 
DMEM. Subsequently, cultures were stimulated with PDGF at 
the concentrations indicated for 24 h. Total RNA transblot was 
probed with the same integrin cDNAs as indicated in Fig. 1. Mo- 
lecular size for c~  2, a3, and ct  5 mRNAs is 8.5, 5.0, and 5.0 kb, re- 
spectively.  Equal loading was monitored by UV light examina- 
tion of ethidium bromide stained gel and confirmed by hybridization 
of the same blot with 32p-labeled probe for 28S ribosomal RNA. 
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H, respectively) compared to either normal dermis (D and G, 
respectively) or collagen-rich 7-d wounds (panels F  and L 
respectively). Thus, the maximal expression of these inte- 
grins in the  cytokine-rich wound environment correlated 
with the presence of abundant ECM ligand. 
PDGF-BB Regulation of a2, a3, and a5 Integrin 
Subunit mRNA 
To assess whether the integrins of interest were PDGF re- 
sponsive,  we  compared mRNA  steady-state  levels from 
normal human dermal fibroblasts grown on plastic dishes 
treated with PDGF-BB for different time periods (Fig. 2) 
and  at different dosages (Fig. 3). PDGF-BB upregulated 
ct  2, et3, and ct5 mRNA (Fig. 2). The mRNA molecules were 
~8.5 kb for et2 and 5.0 kb for ot  3 and et  5 as reported earlier 
(Argraves et al., 1987; Takada and Hemler, 1989; Takada 
et al.,  1991; Tsuji et al.,  1991).  PDGF-induced changes in 
mRNA steady state were first observed 4 h  after addition 
(data not shown) but reached a maximum at 24 h and per- 
sisted for at least 2 d (Fig. 2). 
PDGF regulated integrin mRNA in  a  dose-dependent 
manner (Fig. 3). In general, steady-state mRNA reached a 
maximum change at 13.5 ng/ml PDGF-BB, a dose response 
similar to that of PDGF-stimulated cell proliferation (data 
not shown). One exception was a2 mRNA levels which in- 
creased further with 27.0 ng/ml PDGF-BB. To insure opti- 
mal conditions, we chose PDGF-BB at 30.0 ng/ml and 24 h 
of incubation as our standard condition for the following 
studies. 
ECM Regulation of lntegrin Subunits ~2, a3, and a5 
mRNA Levels 
To  determine  whether  ECM  found  during  the  different 
phases  of wound  repair  differentially  regulates  integrin 
mRNA levels in the absence or presence of PDGF-BB, we 
measured mRNA steady-state levels from cells grown in 
stressed fibrin gel, stressed and relaxed collagen gels as in 
vitro models of early wound clot, late granulation tissues, 
and  normal  dermis,  respectively.  Cells  grown  on  tissue 
plastic dishes were included as a  general control and for 
comparison  with  cells  in  fibrin  gels  since  fibroblasts  in 
these conditions produce an abundant fibronectin pericel- 
lular matrix (Hynes, 1973; Ruoslahti and Vaheri, 1974; Ya- 
mada  and  Weston,  1974).  Compared  to  fibronectin-rich 
tissue culture conditions, basal mRNA levels of oL  3 and et  5 
were  altered  slightly  by collagen  gels,  while  et  2 was  in- 
creased (Fig. 4). There was little if any difference in inte- 
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Figure 4.  Regulation of integrin  mRNAs by PDGF-BB in fibroblasts  cultured  on plastic, stressed  fibrin gel, stressed  and relaxed col- 
lagen gels. Fibroblasts  were cultured  on plastic, in stressed  fibrin, stressed,  and relaxed collagen gels for 1 d in 10% FCS/DMEM fol- 
lowed by 3 d in 1% FCS/DMEM.  Subsequently,  cultures were incubated with fresh DMEM in the absence (-) or presence of 30 ng/ml 
PDGF-BB or platelet releasates (PR) for 24 h. Total RNA was probed with the same integrin cDNAs as indicated  in Fig. 1. (A) North- 
ern blots. (B) Northern blots analyzed by densitometric  scanning. Open, hatched,  and dark bars represent treatment without and with 
PDGF-BB and platelet releasates,  respectively.  TC, tissue culture plastic; sCOL, stressed collagen gel; rCOL, relaxed collagen gel; sFg, 
stressed fibrin gel; PR, platelet releasates.  Equal loading was monitored by UV light examination of ethidium bromide stained gel and 
confirmed by hybridization  of the same blot with 3ep-labeled probe for 28S ribosomal RNA. 
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ct2, ct3, and ct  5 mRNA levels  in fibroblasts cul- 
tured on plastic, stressed fibrin gel, stressed and 
relaxed collagen gels. Fibroblasts were cultured 
on plastic,  in stressed  fibrin,  stressed  and re- 
laxed collagen gels for i  d in 10% FCS/DMEM 
followed by 3  d  in  1%  FCS/DMEM.  Subse- 
quently, cultures were stimulated with 30 ng/ml 
PDGF-BB for the time indicated. Total RNA 
was isolated  and probed with c~2, ct3, and  ct  5 
cDNAs. Equal loading was monitored by UV 
light examination of ethidium bromide stained gel 
and confirmed by hybridization of the same blot 
with 32p-labeled probe for 28S ribosomal RNA. 
grin mRNA levels when cells were cultured in stressed vs 
relaxed collagen gels. Fibroblasts  grown in stressed fibrin 
gels had similar integrin mRNA levels as cells grown in fi- 
bronectin-rich tissue culture conditions. Since cells exhib- 
ited quite  distinct  morphology in stressed  collagen vs re- 
laxed  collagen  gels  and  similar  morphology  in  stressed 
collagen  and fibrin  gels (data  not shown), we concluded 
that although cell shape may play a role in regulating basal 
levels of some genes (Grinnell, 1994; Ingber, 1993; Singhvi 
et al., 1994), ECM regulates integrin expression mainly by 
its chemical nature. 
Influence of ECM on PDGF-BB Regulation of Integrin 
Subunits a2, a 3, and a5 mRNA Levels 
Since  all  integrins  examined were regulated  by recombi- 
nant PDGF-BB when fibroblasts were cultured on plastic 
dishes (Figs. 2 and 3), we examined whether collagen and 
fibrin  gels would  influence  these  PDGF-BB  effects.  Di- 
luted  human  platelet  releasate,  containing  13.5  ng/ml 
PDGF, was included in the  experiment  in parallel  to re- 
combinant PDGF-BB. Integrin a2, et3, and a5 mRNA lev- 
els were all increased by PDGF-BB and platelet releasate 
whether cells were grown in fibronectin-rich culture condi- 
tions or in stressed fibrin gels (Fig. 4). In comparison, col- 
lagen  gels  greatly  attenuated  the  a3  and  e~  5 mRNA  re- 
sponse to PDGF-BB and platelet releasate  and enhanced 
the stimulated increase of ot  2 mRNA. 
Since  other laboratories  have reported  that fibroblasts 
cultured  in  collagen  gels  incrementally  decrease  c-rnyc 
mRNA (Shimbara et al., 1992) and collagen al(I) mRNA 
(Eckes  et  al.,  1993)  during prolonged incubation,  we ex- 
amined  the  effects  of collagen  and fibrin  gel on PDGF- 
stimulated  ct2, or3, and et  5 mRNAs beyond 24 h  of incuba- 
tion. Cells grown in fibronectin-rich culture conditions and 
stressed  fibrin  gel maintained  the same  stimulated  levels 
of et2, or3, and a5 mRNA levels for up to 72 h  (Fig. 5).  In 
contrast, when cultured in collagen gels, a3 and e~  5 mRNA 
returned  to basal levels by 48 h  (Fig.  5).  The  synergistic 
stimulation of a2 mRNA by PDGF and collagen was maxi- 
mal at 24 h but still present at 48 h. 
Collagen Gels Impair the Ability of PDGF-BB to 
Increase a3 and a5 mRNA Stability 
Since collagen gels appeared to shorten the response time 
as well as blunt the maximal response of ct  3 and as mRNA 
to  PDGF-BB,  the  effect  of collagen  gels  on  et  3 and  et  5 
mRNA stability was examined. An RNA transcription ini- 
tiation  inhibitor,  DRB, at  60 }xM was used  to treat  cells 
grown in fibronectin-rich tissue culture conditions and in 
relaxed collagen gel with or without PDGF-BB. Quantita- 
tive Northern  analysis of ot  3 and et  5 mRNAs were  exam- 
ined as a function of time. In cells grown in tissue culture 
conditions and treated with PDGF-BB, a clear increase in 
stability  of et  3 and o~  5 mRNAs was detected compared to 
cells not treated with PDGF-BB (Fig. 6). In contrast, cells 
grown in collagen gel demonstrated no significant increase 
in a3 and ot  5 mRNA stability with PDGF-BB treatment.  It 
thus appears that fibroblasts in collagen gels are unable to 
increase ot  3 and ot  5 mRNA levels in response to PDGF par- 
tially due to their inability to stabilize et  3 and a5 mRNAs. 
PDGF Increases a 2 mRNA Stability When Fibroblasts 
Are Cultured in Collagen, but Not on Plastic 
To address whether collagen abrogated PDGF regulation 
of mRNA stability of all integrins,  ot  2 mRNA stability  of 
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Figure  6.  Effects  of PDGF- 
BB on stability of integrin o~  3 
and  ct  5  mRNAs  from  cells 
cultured on plastic and relaxed 
collagen gel. Fibroblasts were 
cultured  on  plastic  and  re- 
laxed collagen gel for 1 d in 
10% FCS/DMEM followed by 
3 d in 1% FCS/DMEM. Day 4 
cultures were treated with an 
RNA synthesis inhibitor, 5,6- 
dichloro-l13-D-ribofuranosyl- 
benzimidazole (DRB), 15 min 
before  experimental  condi- 
tions.  Total  RNA  was  iso- 
lated at 0 h; 4 h; 8 h and 24 h, 
and  probed  with  c~3  and  c~  5 
cDNAs.  (A) Northern  blots. 
(B)  Densitometric  scans  of 
Northern  blots.  Open  and 
dark  circles  represent  with- 
out  and  with  PDGF-BB 
treatment, respectively. Equal 
loading  was  monitored  by 
UV light examination of ethid- 
ium bromide stained gel and 
confirmed  by  hybridization 
of  the  same  blot  with  32p_ 
labeled probe for 28S riboso- 
mal RNA. 
cells  grown  in  fibronectin-rich  tissue  culture  conditions 
and in collagen gels was compared. Because the basal level 
of ot  2 mRNA  from cells grown  on tissue  culture  dishes  is 
almost  nondetectable,  ~2  mRNA  was  first  induced  with 
PDGF  and  then  its  decay  rate  determined.  Surprisingly, 
cells  grown  in  fibronectin-rich  tissue  culture  conditions 
failed  to  increase  a2  mRNA  stability  in  response  to 
PDGF-BB  (Fig.  7).  In  contrast,  PDGF  significantly  in- 
creased oL  2 mRNA  stability in cells grown in collagen gels 
(Fig.  7). Therefore, the synergistic effects of collagen gels 
and PDGF on ot  2 mRNA  clearly involve mRNA  stability. 
Thus, posttranscriptional regulation appears to play an im- 
portant  role  in both PDGF  and  ECM control  of integrin 
expression. 
Discussion 
The  early  wound  environment  is  composed  of  a  provi- 
sional  matrix  consisting  largely  of fibrin  and  fibronectin 
and a fluid-phase milieu rich in factors arising mostly from 
degranulated  platelets  (Clark,  1993).  Among  the  compo- 
nents of this platelet cocktail, PDGF stands out as a potent 
mesenchymal  cell mitogen  and  chemoattractant  (Ross  et 
al.,  1990).  To move into and  through  the provisional ma- 
trix, however, the cells must express the integrin receptors 
that  can  bind  fibrin,  fibronectin,  or  vitronectin  (Hynes, 
1992;  Ruoslahti,  1991).  In this report we demonstrate  that 
fibroblasts moving into the provisional matrix of a  wound 
dramatically  upregulate  the  fibronectin  receptors,  et3131 
and ets[31, but not the collagen receptor a2131 (Fig.  1). 0t2131 
receptors increase later at 7 d when great quantities of col- 
lagen matrix accumulate in the wound (Welch et al., 1990; 
Clark  et  al.,  1995a).  Human  dermal  fibroblasts  cultured 
with  PDGF-BB  either  in  fibronectin-rich  tissue  culture 
conditions  or in fibrin gels, conditions  that approximate an 
early  wound  environment,  increase  mRNA  steady-state 
levels of provisional matrix integrin receptors compared to 
collagen  receptors  (Fig.  4).  Fibroblasts  cultured  in  col- 
lagen gels, conditions  that approximate normal dermis or 
later wound environments,  fail to give this response even 
in  the  presence  of PDGF.  Clearly  these  results  demon- 
strate that ECM and PDGF act synergistically to generate 
the  proper cellular signal(s)  to elicit integrins  needed  for 
the situation at hand. 
PDGF-BB  is a  known  positive regulator  of integrin  ot  5 
and  133 mRNA  in aortic smooth muscle cells (Janat et al., 
1992), ot  2 in human foreskin fibroblasts (Alden and Kristofer, 
1994) and ~1  gene transcription  in Swiss 3T3 mouse fibro- 
blasts (Bellas et al., 1991). Here we studied its influence in 
normal human  dermal  skin  fibroblasts  on ot  2 collagen re- 
ceptor subunit  mRNAs,  and ct  3, et  5 provisional matrix re- 
ceptor subunit  mRNAs  (Figs.  2  and  3),  and  the  modula- 
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Figure 7.  Effects of PDGF- 
BB on stability of integrin c,  2 
mRNAs from cells  cultured 
on plastic and in relaxed col- 
lagen gels. Fibroblasts were 
cultured  on plastic and in re- 
laxed collagen gels for 1 d in 
10%  FCSfDMEM  followed 
by 3  d  in  1%  FCS/DMEM. 
Day 4 cultures  were treated 
with 30 ng/ml PDGF-BB for 
24  h.  Extensively  washed 
cells were then treated with 
DRB with or without PDGF- 
BB. Total RIgA was isolated 
at 0 h; 4 h; 8 h and 24 h, and 
probed  with  a2 cDNA.  (A) 
Northern blots.  (B) Densito- 
metric  scans  of  Northern 
blots.  Open and dark circles 
represent  without  and  with 
PDGF-BB  treatment,  re- 
spectively. Equal loading was 
monitored  by UV  light  ex- 
amination  of  ethidium  bro- 
mide  stained  gel  and  con- 
firmed by hybridization of the 
same  blot  with  32p-labeled 
probe for 28S ribosomal RNA. 
tion of its effects by two distinct types of ECM, collagen, 
and fibrin gels (Fig. 4). 
When  fibroblasts were  cultured  in  fibrin gels  they re- 
sponded to PDGF in a fashion similar to fibroblast on plas- 
tic (Fig. 4). This finding is perhaps not so surprising when 
one considers that fibroblasts cultured on plastic form a fi- 
bronectin-rich pericellular matrix (Hynes, 1973; Ruoslahti 
and Vaheri, 1974; Yamada and Weston, 1974).  Thus fibro- 
blasts in an environment of either fibrin or fibronectin re- 
sponded to PDGF by increasing ot  3 and e~  5 mRNAs for the 
integrin  receptors  that  interact  with  these  proteins.  The 
PDGF-induced increases in et3 and ot  5 mRNA observed in 
fibrin/fibronectin-cultured fibroblasts were attenuated when 
fibroblasts were cultured in collagen while the increase in 
a2 mRNA was accentuated. The overall effect of collagen- 
cultured fibroblasts in the presence or absence of PDGF 
was to increase their collagen receptor mRNAs and decrease 
their  provisional matrix receptor  mRNAs.  The  integrin 
responses of fibroblasts in these various culture conditions 
to human platelet releasate containing  13.5  p.g/ml PDGF 
were parallel to the responses to recombinant PDGF-BB 
(Fig. 4). 
Collagen  gel  attenuation  of PDGF-stimulated  integrin 
a3 and a5 mRNA levels evokes a  familiar theme of sup- 
pression of cell responsiveness to growth factors, such as 
PDGF-stimulated DNA synthesis (Nishiyama et al., 1991) 
and TGFq3-induced type I collagen synthesis (Clark et al., 
1995a). However, the similar regulatory pattern of a3 and 
ot  5 by collagen and PDGF-BB was initially disconcerting 
since we expected that a3 would respond to these agents 
similar to ot2131 since the ot3~  1 integrin was known as a re- 
ceptor for collagen by affinity chromatography and anti- 
body  blocking  of  cell  adhesion  to  collagen-coated  sub- 
strata (Eliees et al., 1991; Takada et al., 1988; Wayner and 
Carter, 1987). However, a3~1 has several features different 
from collagen receptors a1131 and a2131: (a) GuUberg et al. 
(1992) found that a3131 is not involved in the initial attach- 
ment of rat hepatocytes and cardiac fibroblasts to type I 
collagen as judged  by affinity chromatography and  anti- 
body blocking of the  cell  adhesion;  (b)  unlike  eq~  1 and 
a21~1, a3~1 has no collagen binding I-domain but rather is a 
RGD-dependent  receptor  for  fibronectin  (Elices  et  al., 
1991);  (c)  et3131 recognizes  denatured  type  I  collagen 
(Yamamoto  and  Yamamoto,  1994)  possibly through  an 
RGD-dependent mechanism (Aumailley et al., 1989; Pfaff 
et al.,  1993;  Vandenberg et al.,  1991)  in contrast to et1131 
and 0t2131 binding to collagen via non-RGD sites (Kupper 
and Ferguson,  1993;  Staatz et al., 1991).  Thus the similar 
modulation of ot  3 and a5 mRNAs is concordant with the 
possibility that e~3131 in human fibroblasts is a  provisional 
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than a receptor for native collagen. 
Although there are several reports that relaxed collagen 
gels  attenuate  the  PDGF-responsiveness  of  fibroblasts 
more than stressed collagen gels (for review see Grinnell, 
1994), we failed to observe such differences among the in- 
tegrin subunit mRNAs. We did confirm, however, that fi- 
broblasts are elongated in stressed collagen gels and stel- 
late in relaxed collagen gels  (data not shown) and that 
PDGF-stimulated fibroblast proliferation rate is more at- 
tenuated by relaxed collagen gels than stressed collagen 
gels (data not shown). For the most part, however, it ap- 
pears that collagen matrix modulation of both basal and 
PDGF-regulated integrin mRNA levels are achieved by 
the biochemical nature of the collagen and not by isotropic 
or  anisotropic  forces  established  within  a  three-dimen- 
sional collagen gel. Although cell shape has often been im- 
plicated  in  cell  function (Folkman and  Moscona,  1978; 
Ingber, 1993), more and more evidence showed that inte- 
grin-mediated changes in intracellular milieu can occur in 
the absence of changes in cell morphology or overt reorga- 
nization of actin microfilaments (Werb et al.,  1989). For 
example, interaction of a5131 with fibronectin induced cyto- 
plasmic alkalization by activating the Na+/H ÷ antiporter 
without involving cell shape (Ingber et al., 1990; Schwartz 
et al., 1991). Therefore it is possible that in our systems, 
interaction  of  collagen  with  its  receptors,  rather  than 
changes in cell shape, sends signals distinct from those sent 
by fibrin or fibronectin receptor interaction. The chemical 
nature of the ECM would be more important than physi- 
cal nature of the ECM in this type of regulation. Indeed, 
ECM and growth factor stimuli may cooperate at the level 
of second messengers or genes to achieve control of gene 
expression. 
Collagen gel enhancement of PDGF-stimulated o~  2 mRNA 
level provided new insight into collagen's role on growth 
factor  regulation  of cellular  function.  Grinnell  and  co- 
workers have observed that PDGF receptor autophosphor- 
ylation was  impaired  when  human  foreskin  fibroblasts 
were cultured in relaxed collagen gel (Lin and Grinnell, 
1993) and Marx et al. (1993)  have reported that collagen 
gels reduce PDGF receptor 13 subunits (Lin and Grinnell, 
1994;  Marx  et  al.,  1993).  Thus  collagen  modulation  of 
PDGF pathways might occur at a very early stage of the 
stimulation. On  the other hand, since we detected both 
positive and negative impact of collagen gels on PDGF- 
stimulation of selective integrins and since increasing evi- 
dence showed that ECM-induced signal pathways share 
several components identified in growth factor or cytokine 
pathways, e.g., G-protein (Symons and Mitchison, 1992), 
src family kinase (Huang et al., 1991), PIP2 (McNamee et 
al., 1993), and phospholipase D (Yeo et al., 1995), it is pos- 
sible  that  more  distal  point(s)  along  PDGF  regulatory 
pathways may be affected by ECM. This would allow a di- 
versified pattern of the combinatorial effects of ECM and 
PDGF on cell activities. We confirmed the general view 
that collagen gel possesses a suppressive nature by show- 
ing  that  the  PDGF-stimulation  of  integrin  ct  3  and  ct  5 
mRNA levels was attenuated by collagen gels. However, 
the collagen gel can also synergize with PDGF on increas- 
ing integrin et  2 mRNA levels. 
The mechanisms by which ECM and growth factors co- 
operate with one another largely remain unclear. In this 
study, we describe a novel mechanism by which collagen 
gels modulate fibroblast responsiveness to PDGF. PDGF- 
stimulated integrin %  and %  mRNA steady-state levels 
were  attenuated  by collagen gels  through  alteration  in 
message half-life. Our experiments clearly showed that ot  3 
and or5 integrin mRNAs from fibroblasts cultured in col- 
lagen gels had shorter half-lives than the mRNAs from 
cells  cultured  on  plastic  in  the  presence  or  absence  of 
PDGF (Fig. 6).  On the  other hand, PDGF greatly pro- 
longed ot  2 mRNA half-life when fibroblasts were cultured 
in collagen gels, but did not have any effect on oL  2 mRNA 
stability  from  cells  cultured  on  plastic  (Fig.  7).  Thus 
mRNA  stability clearly played a  role  in  the  ECM  and 
PDGF regulation of integrins. 
Collagen posttranscriptional regulation of gene expres- 
sion has been reported for albumin in mouse hepatocytes 
(Zaret et al., 1988) and collagen al(I) in adult dermal hu- 
man fibroblasts (Berthod et al., 1994; Eckes et al., 1993). A 
comprehensive review by Juliano and Haskill of integrin- 
mediated  adhesion-induced  immediate  early  genes  in 
monocytes, revealed that all responsive genes contained 
repetitive AU-rich sequences which regulate mRNA sta- 
bility  and  translational  efficiency (Juliano  and  Haskill, 
1993). Therefore, the ECM may alter integrin expression, 
in large part, through regulation of mRNA stability. 
Based on our results reported here and ongoing in vivo 
studies, we propose a working hypothesis for the initiation 
of wound repair. After injury, fibrinogen/fibronectin and 
PDGF leak from blood vessels around the wound and en- 
velop biosynthetically inactive fibroblasts that were previ- 
ously embedded in a collagen-rich matrix. The combina- 
tion of fibrin/fibronectin provisional matrix environment 
and PDGF stimulates fibroblasts to proliferate and to ex- 
press relatively high levels of provisional matrix receptor 
mRNAs compared to collagen receptor mRNAs. This al- 
teration in integrin mRNA steady state ultimately leads to 
surface changes in integrin receptors  (Gailit and  Clark, 
1995).  Once accumulation of provisional matrix integrins 
on the cell surface reaches threshold (3 or 4 d after the ini- 
tial signals), cells migrate into the clot-filled wound space 
under the direction of chemotactic signals and stay there 
via ECM-integrin recognition forces (Clark et al., 1995b). 
In a provisional matrix bed, cells respond to growth factors 
and cytokines by additional proliferation and new ECM 
synthesis. Once a new matrix of collagen prevails, collagen 
attenuates cell proliferation and ECM synthesis and stim- 
ulates ct  2 integrin synthesis synergistically with PDGF to 
facilitate collagen contraction and ECM reorganization. 
In summary ECM and growth factors have the ability to 
coordinately alter  cell phenotypes. The  pretranslational 
events reported by this paper clearly support this concept. 
The posttranslational events are on-going studies in our 
lab. Specifically we show here a mechanism by which cells 
can  respond  differently to  repeated  stimulation  by the 
same growth factor. Since cells have the ability to secrete 
ECM, the matrix environment continuously changes lead- 
ing to a progression of cell phenotypes even in the face of 
a constant growth factor milieu. Ultimately the changes in 
cell phenotype and ECM results in new tissue formation. 
Coordinate ECM and growth factor regulation of cell phe- 
notype probably is partially responsible for tissue develop- 
Xu and Clark Integrin Regulation by ECM and PDGF  247 ment during embryogenesis and morphogenesis (Schmidt, 
1994) as well as wound repair (Clark et al., 1995a; Clark, 
1995). 
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